Leading clinical trials at Rose
The experienced cancer care team at Sarah Cannon at Rose Medical Center is constantly exploring the latest treatment options available as well as the most innovative techniques for the detection and prevention of cancer. Sometimes, traditional or standard therapies are not effective for more complex cancers, but that is not a reason to give up hope.
What are clinical trials?
Clinical trials are research studies conducted to answer important medical and scientific questions with the ultimate hope of finding better ways to treat diseases, such as cancer. Clinical trials are used to evaluate the safety and effectiveness of new or investigational drugs, combinations of new and/or existing drugs and drug delivery methods.
Access to newer treatments is offered in the hopes that they will be more effective than standard treatments and offer hope to patients who might not be responding to existing therapies.
Intraoperative radiation therapy clinical trial
Sarah Cannon at Rose Medical Center has the leading clinical trial for intraoperative radiation therapy (IORT) in the U.S. For eligible patients* with early stage breast cancer, a lumpectomy, along with the radiation therapy, is often included in the treatment plan. For eligible patients, IORT is an option that delivers the entire course of radiation therapy in the operating room at the time of the lumpectomy, and that is it—as opposed to traditional radiation therapy where the patient goes to as many as five treatments a week for up to eight weeks.
The IORT procedure allows the surgeon to remove the cancerous tumor while conserving as much of the healthy breast tissue as possible.
This clinical trial is led by Rose surgeon Dr. Barbara Shwartzberg who states, “IORT is a significant advancement in the treatment of breast cancer, offering women a less burdensome option to traditional radiation therapy and mitigating the arduous road to recovery many of these patients face. The data presented shows positive outcomes with no recurrence of cancer, further validating the efficacy of IORT for women with early-stage breast cancer.”
*Eligible patients typically include those over the age of 40 with a single focus of cancer (invasive ductal carcinoma). Talk to your physician about eligibility.
Clinical trial partners
Rose is proud to partner with multiple leading physicians to conduct cutting-edge clinical trials. We partner with the US Oncology Network to offer patients access to national studies. Currently, RMCC is participating in approximately 140 clinical research trials in all major cancer types and have a dedicated research staff of nearly 30 people.
About Sarah Cannon Cancer Institute
Rose Medical Center is part of Sarah Cannon, the Cancer Institute of HCA Healthcare. Our family of hospitals provides comprehensive cancer services with convenient access to cutting-edge therapies for people facing cancer in our communities. From diagnosis, to treatment and survivorship care, our oncology expertise ensures you have access to locally-trusted care with the support of a globally-recognized network.
Have cancer questions? We can help. askSARAH is a dedicated helpline for your cancer-related questions. Our specially-trained nurses are available 24/7 and all calls are confidential. Contact askSARAH at (303) 253-3225 or chat online at askSARAHnow.com.